The global Antibody Drug Conjugates Contract Manufacturing Market is witnessing strong expansion driven by rising oncology drug development and increasing outsourcing of complex biologics production. According to industry analysis, the market is expected to grow significantly from 11.46 billion US dollars in 2025 to 25.54 billion US dollars by 2034, registering a CAGR of 9.31% during 2026 to...